Mirati Therapeutics is the subject of takeover speculation in the biopharma sector once again, as it waits for the FDA's decision on its KRAS inhibitor adagrasib in non-small cell lung cancer (NSCLC).

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati's adagrasib as Krazati for a form of lung cancer. Krazati has been cleared as a treatment for ...

After hours: February 13 at 4:09:41 PM EST Loading Chart for ACHL ...

Dyne Therapeutics Inc.-5.60% $1.56B ...

How to revive an 18th-century upstate farmhouse without resorting to cliché? By pretending a made-up person lives there too. By Alice Newell-Hanson and Blaine Davis From a tiny French ...

Want to create a living room that looks (and feels) luxurious? Here are 5 home decor and interior design hacks to turn your living room into a stylish retreat.

We have many care options to help you manage and maintain your health, through the variety of programs and services we offer. Know your options, so you can get the right care, when you need it most.

Get free access to Word, Excel, and PowerPoint using Microsoft 365 for the web (formerly Office).